The link between platelet reactivity and arterial thrombosis risk is well-established, yet incorporating the measurement of platelet reactivity into routine clinical practice has proved impossible—until now.
HaemAnalytica has developed a groundbreaking technology that utilizes platelet surface protein expression to identify intrinsic platelet reactivity without the necessity of measuring platelet function.
This patented innovation is currently being tested for use improving patient therapy after heart attacks and strokes.
